Tuoxin Pharmaceutical: Net loss of 18.2805 million yuan in the first half of 2025
Tuoxin Pharmaceutical announced that its operating revenue in the first half of 2025 was 182 million yuan, a year-on-year decrease of 16.85%. The net loss was 18.2805 million yuan, compared to a loss of 1.7793 million yuan in the same period last year
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments